BSE Live
Dec 09, 16:01Prev. Close
3757.95
Open Price
3740.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 09, 15:57Prev. Close
3760.00
Open Price
3760.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Torrent Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 169.23 | 169.23 | 169.23 | 84.62 | 84.62 | |
| Total Share Capital | 169.23 | 169.23 | 169.23 | 84.62 | 84.62 | |
| Reserves and Surplus | 7,423.27 | 6,659.53 | 6,286.73 | 6,260.80 | 5,945.48 | |
| Total Reserves and Surplus | 7,423.27 | 6,659.53 | 6,286.73 | 6,260.80 | 5,945.48 | |
| Total Shareholders Funds | 7,592.50 | 6,828.76 | 6,455.96 | 6,345.42 | 6,030.10 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 1,020.59 | 1,603.78 | 2,331.78 | 1,971.60 | 2,941.07 | |
| Deferred Tax Liabilities [Net] | 828.48 | 655.81 | 401.30 | 193.56 | 0.00 | |
| Other Long Term Liabilities | 82.78 | 17.49 | 29.20 | 7.79 | 10.14 | |
| Long Term Provisions | 337.78 | 282.15 | 244.54 | 210.83 | 193.93 | |
| Total Non-Current Liabilities | 2,269.63 | 2,559.23 | 3,006.82 | 2,383.78 | 3,145.14 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 1,526.25 | 1,729.18 | 2,233.78 | 1,371.81 | 1,443.36 | |
| Trade Payables | 767.11 | 759.76 | 610.63 | 624.21 | 648.05 | |
| Other Current Liabilities | 478.78 | 328.92 | 414.11 | 307.00 | 387.56 | |
| Short Term Provisions | 207.49 | 170.74 | 150.63 | 120.34 | 106.83 | |
| Total Current Liabilities | 2,979.63 | 2,988.60 | 3,409.15 | 2,423.36 | 2,585.80 | |
| Total Capital And Liabilities | 12,841.76 | 12,376.59 | 12,871.93 | 11,152.56 | 11,761.04 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 3,131.39 | 3,204.97 | 2,687.49 | 2,619.36 | 2,745.31 | |
| Intangible Assets | 4,422.65 | 4,780.95 | 5,284.36 | 3,631.89 | 3,995.93 | |
| Capital Work-In-Progress | 365.59 | 203.94 | 674.90 | 543.54 | 554.84 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 7,955.88 | 8,212.15 | 8,669.78 | 6,818.75 | 7,329.35 | |
| Non-Current Investments | 410.52 | 322.27 | 205.12 | 183.66 | 174.87 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 28.33 | |
| Long Term Loans And Advances | 3.37 | 2.51 | 2.50 | 1.75 | 2.02 | |
| Other Non-Current Assets | 123.19 | 98.60 | 67.45 | 88.35 | 84.59 | |
| Total Non-Current Assets | 8,492.96 | 8,635.53 | 8,944.85 | 7,092.51 | 7,619.16 | |
| CURRENT ASSETS | ||||||
| Current Investments | 112.21 | 141.04 | 156.09 | 183.98 | 139.05 | |
| Inventories | 1,560.83 | 1,565.59 | 1,602.23 | 1,797.11 | 1,911.74 | |
| Trade Receivables | 2,170.79 | 1,571.94 | 1,729.44 | 1,541.35 | 1,544.26 | |
| Cash And Cash Equivalents | 109.74 | 108.76 | 147.61 | 69.46 | 66.42 | |
| Short Term Loans And Advances | 4.22 | 3.05 | 1.71 | 2.61 | 3.08 | |
| OtherCurrentAssets | 391.01 | 350.68 | 290.00 | 465.54 | 477.33 | |
| Total Current Assets | 4,348.80 | 3,741.06 | 3,927.08 | 4,060.05 | 4,141.88 | |
| Total Assets | 12,841.76 | 12,376.59 | 12,871.93 | 11,152.56 | 11,761.04 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 1,368.98 | 1,395.40 | 1,448.95 | 1,296.42 | 1,155.38 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 635.31 | 468.65 | 373.53 | 333.74 | 713.61 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | 2,696.06 | 2,323.91 | 2,099.42 | 1,841.91 | 2,153.94 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 162.41 | 162.41 | 162.41 | 77.80 | 77.80 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 410.52 | 322.27 | 205.12 | 183.66 | 174.87 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 112.21 | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | 183.98 | 139.05 |
14.11.2025
Torrent Pharma Consolidated September 2025 Net Sales at Rs 3,302.00 crore, up 14.3% Y-o-Y
12.11.2025
Torrent Pharma Standalone September 2025 Net Sales at Rs 2,762.00 crore, up 13.48% Y-o-Y
29.07.2025
Torrent Pharma Consolidated June 2025 Net Sales at Rs 3,178.00 crore, up 11.16% Y-o-Y
29.07.2025
Torrent Pharma Standalone June 2025 Net Sales at Rs 2,616.00 crore, up 7.3% Y-o-Y
12.07.2023
Torrent Pharma Q1 PAT may dip 9.7% YoY to Rs 319.7 cr: Nirmal Bang
17.01.2023
Torrent Pharma Q3 PAT seen up 28.9% YoY to Rs 3,211 cr: Nirmal Bang
13.07.2022
Torrent Pharma Q1 PAT seen up 2.8% YoY to Rs 339.1 cr: ICICI Direct
08.07.2022
Torrent Pharmaceuticals Q1 PAT seen up 1.4% YoY to Rs 334.5 cr: Prabhudas Lilladher
24.07.2019
Torrent Pharma shares jump 6% as brokerages remain bullish after Q1 show
25.08.2018
Pharma Q1 review: Brokerages say performance a mixed bag, but are upbeat on domestic biz
22.01.2014
14.01.2012